Monod Bio Licenses AI-Designed Proteins to Sino Biological Unit
AI is moving deeper into biological research, with protein-design models increasingly being used to create molecules that can perform specific functions rather than simply analyze existing biological data. Monod Bio and SignalChem Biotech, a wholly owned subsidiary of Sino Biological, are taking that trend into commercial life-science services through a new non-exclusive licensing agreement covering…
